WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

Md. Kalam Ansari, Md. Razi Ahmad, Md. Najibur Rahman and Md. Tanwir Alam*

ABSTRACT

Historical background: According to Ibn-e-Habal, Niqris originated from the word „Anquroon’ which means big toe of foot, because this disease usually starts with the involvement of this particular joint and hence the disease has been named after this joint.[1,2,3] Gout comes from the Latin „Gutta?-which means „Drop? (Noxa) - with reference to the mediaeval “flowing down of humour”. Which justify the ancient belief about disease matter i.e. humours falling down drop by drop into the joint.[4,5,6] Incidence of gout is on rise with time and the prevailed mainstream treatment is not effective that mush as required. So, this unani formulation has been decided to testify scientifically and to prove its efficacy on patients of gout; which has been claimed in classical Unani text. Study Design: Present study has been designed to study the efficacy of a compound Unani formulation drug in the management of Niqris (Gout). It is an open clinical trial. The efficacy of this drug has been evaluated on the basis of standard parameters, subjective and objective both. The study was conducted on 60 patients for duration of 60 days. Result: After Intervention, most of the subjective parameters improved significantly, on objective parameters, improvement is very significant. All the biochemical parameters P=0.001. This result suggesting the effect of test drug is very effective in lowering the serum uric acid. Findings of trial were recorded on a specially designed chart and inference was made by appropriate statistical analysis.

[Full Text Article] [Download Certificate]